Lattice Biologics Ltd. (LBLTF)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Nov 9, 2026
Lattice Biologics Market Cap
Lattice Biologics has a market cap or net worth of $128 as of November 13, 2026. It is the 52,920th most valuable company in the world and the 8,852nd biggest in the United States.
Market Cap
128.00
Enterprise Value
n/a
Revenue
1.56M
Global Rank
Country Rank
#8,852 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since February 10, 2016, Lattice Biologics's market cap has decreased from 9.68M to 128.00, a decrease of -100.00%. That is a compound annual growth rate of -64.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 128.00 | - |
| Dec 27, 2023 | 128.00 | -99.99% |
| Dec 27, 2021 | 1.80M | -53.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Avitar | 731.00 |
| Enchanted World | 593.00 |
| STRATA Skin Sciences | 589.00 |
| Manhattan Scientifics | 559.00 |
| Southwestern Medical Solutions | 405.00 |
| ViewRay Systems | 183.00 |
| Zecotek Photonics | 165.00 |
| CVR Medical | 132.00 |